Oneness Biotech Co., Ltd. (4743.TWO)
TWD 87.4
(-2.13%)
TWD 87.4
(-2.13%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 397.95 Million TWD | 64.05% |
| 2022 | 263.44 Million TWD | -7.18% |
| 2021 | 283.82 Million TWD | -6.36% |
| 2020 | 303.08 Million TWD | -7.77% |
| 2019 | 328.6 Million TWD | 405590.12% |
| 2018 | 81 Thousand TWD | 224.0% |
| 2017 | 25 Thousand TWD | 25.0% |
| 2016 | 20 Thousand TWD | -63.64% |
| 2015 | 55 Thousand TWD | -99.35% |
| 2014 | 8.49 Million TWD | -5.81% |
| 2013 | 9.02 Million TWD | 7.0% |
| 2012 | 8.43 Million TWD | 76.82% |
| 2011 | 4.76 Million TWD | 19.41% |
| 2010 | 3.99 Million TWD | 5295.95% |
| 2009 | 74 Thousand TWD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 428.51 Million TWD | -0.85% |
| 2024 Q2 | 425.9 Million TWD | -0.61% |
| 2023 Q4 | 432.19 Million TWD | 71.12% |
| 2023 FY | 432.19 Million TWD | 64.05% |
| 2023 Q1 | 258.63 Million TWD | -1.83% |
| 2023 Q2 | 259.13 Million TWD | 0.2% |
| 2023 Q3 | 252.57 Million TWD | -2.53% |
| 2022 Q1 | 277.49 Million TWD | -2.23% |
| 2022 Q2 | 263.99 Million TWD | -4.87% |
| 2022 Q3 | 261.45 Million TWD | -0.96% |
| 2022 Q4 | 263.44 Million TWD | 0.76% |
| 2022 FY | 263.44 Million TWD | -7.18% |
| 2021 Q1 | 299.6 Million TWD | -1.15% |
| 2021 FY | 283.82 Million TWD | -6.36% |
| 2021 Q2 | 294.42 Million TWD | -1.73% |
| 2021 Q3 | 283.72 Million TWD | -3.63% |
| 2021 Q4 | 283.82 Million TWD | 0.03% |
| 2020 Q4 | 303.08 Million TWD | -0.68% |
| 2020 Q1 | 320.2 Million TWD | -2.56% |
| 2020 Q2 | 316.63 Million TWD | -1.12% |
| 2020 Q3 | 305.15 Million TWD | -3.62% |
| 2020 FY | 303.08 Million TWD | -7.77% |
| 2019 Q2 | 356.49 Million TWD | 8.42% |
| 2019 FY | 328.6 Million TWD | 405590.12% |
| 2019 Q3 | 367.41 Million TWD | 3.06% |
| 2019 Q1 | 328.82 Million TWD | 405853.09% |
| 2019 Q4 | 328.6 Million TWD | -10.56% |
| 2018 Q1 | 66 Thousand TWD | 164.0% |
| 2018 FY | 81 Thousand TWD | 224.0% |
| 2018 Q4 | 81 Thousand TWD | 68.75% |
| 2018 Q3 | 48 Thousand TWD | 54.84% |
| 2018 Q2 | 31 Thousand TWD | -53.03% |
| 2017 Q1 | 25 Thousand TWD | 25.0% |
| 2017 Q3 | 15 Thousand TWD | 200.0% |
| 2017 Q2 | 5000.00 TWD | -80.0% |
| 2017 Q4 | 25 Thousand TWD | 66.67% |
| 2017 FY | 25 Thousand TWD | 25.0% |
| 2016 FY | 20 Thousand TWD | -63.64% |
| 2016 Q4 | 20 Thousand TWD | 300.0% |
| 2016 Q3 | 5000.00 TWD | -98.77% |
| 2016 Q2 | 407 Thousand TWD | 3970.0% |
| 2016 Q1 | 10 Thousand TWD | -81.82% |
| 2015 Q1 | 8.45 Million TWD | -0.55% |
| 2015 FY | 55 Thousand TWD | -99.35% |
| 2015 Q3 | - TWD | 0.0% |
| 2015 Q4 | 55 Thousand TWD | 0.0% |
| 2015 Q2 | - TWD | -100.0% |
| 2014 Q2 | 8.43 Million TWD | -1.84% |
| 2014 Q1 | 8.59 Million TWD | -4.73% |
| 2014 FY | 8.49 Million TWD | -5.81% |
| 2014 Q4 | 8.49 Million TWD | 0.24% |
| 2014 Q3 | 8.47 Million TWD | 0.49% |
| 2013 FY | 9.02 Million TWD | 7.0% |
| 2013 Q4 | 9.02 Million TWD | 6.56% |
| 2013 Q3 | 8.46 Million TWD | 0.39% |
| 2013 Q2 | 8.43 Million TWD | -2.45% |
| 2013 Q1 | 8.64 Million TWD | 2.54% |
| 2012 Q4 | 8.43 Million TWD | -1.59% |
| 2012 Q1 | 2.3 Million TWD | -51.64% |
| 2012 Q2 | 5.75 Million TWD | 149.39% |
| 2012 FY | 8.43 Million TWD | 76.82% |
| 2012 Q3 | 8.56 Million TWD | 48.97% |
| 2011 Q3 | 4.09 Million TWD | 421.27% |
| 2011 Q4 | 4.76 Million TWD | 16.52% |
| 2011 Q1 | 531 Thousand TWD | -86.7% |
| 2011 Q2 | 785 Thousand TWD | 47.83% |
| 2011 FY | 4.76 Million TWD | 19.41% |
| 2010 FY | 3.99 Million TWD | 5295.95% |
| 2010 Q4 | 3.99 Million TWD | 0.0% |
| 2009 FY | 74 Thousand TWD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Bio Preventive Medicine Corp. | 113.44 Million TWD | -250.781% |
| Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | -40.315% |
| Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -45641.379% |
| Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | -48.145% |
| NaviFUS Corp. | 32.69 Million TWD | -1117.233% |
| G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | -7227.38% |
| TaiRx, Inc. | 12.28 Million TWD | -3139.053% |
| Sinew Pharma Inc. | 6.46 Million TWD | -6056.405% |
| Lin BioScience, Inc. | 42.87 Million TWD | -828.207% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | -33883.775% |
| Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | -3055.829% |
| Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | -28674.403% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | 1.193% |
| AP Biosciences Inc | 82.07 Million TWD | -384.838% |
| Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | -128.591% |
| RBC Bioscience Corporation | 487.36 Million TWD | 18.346% |
| Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 41.629% |
| EirGenix Inc. | 465.16 Million TWD | 14.45% |
| Enimmune corporation | 45.73 Million TWD | -770.14% |
| Lukas Biomedical Inc. | 82.55 Million TWD | -382.042% |
| BRIM Biotechnology, Inc. | 3.59 Million TWD | -10978.786% |
| 3D Global Biotech Inc. | 10.37 Million TWD | -3734.184% |
| TaiMed Biologics Inc. | 750.85 Million TWD | 47.0% |
| Mycenax Biotech Inc. | 726.27 Million TWD | 45.207% |
| TCI GENE Inc. | 6.79 Million TWD | -5756.512% |
| SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | -18724.503% |
| Eusol Biotech Co.,Ltd. | 4.35 Million TWD | -9039.871% |
| Feng Chi Biotech Corp. | 10.79 Million TWD | -3585.405% |
| NeoCore Technology Co., Ltd. | 96.89 Million TWD | -310.719% |
| TWi Biotechnology, Inc. | 7.97 Million TWD | -4892.473% |
| Neith Corporation | 3.54 Million TWD | -11138.351% |
| Sunny Pharmtech Inc. | 391.42 Million TWD | -1.666% |
| VBI | - TWD | -Infinity% |
| Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | -6647.202% |
| GeneReach Biotechnology Corp. | 257.03 Million TWD | -54.821% |
| Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -73868.401% |
| CHO Pharma, Inc. | - TWD | -Infinity% |
| Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | -1367.313% |
| MegaPro Biomedical Co., Ltd | 8.31 Million TWD | -4684.203% |
| Visgeneer Inc. | 158.6 Million TWD | -150.905% |
| Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | -102.897% |
| BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | -583.692% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | 4.572% |
| Sagittarius Life Science Corp | 13.32 Million TWD | -2886.94% |
| BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | -2939.643% |
| GlycoNex Incorporation | 900 Thousand TWD | -44116.667% |
| Medigen Biotechnology Corp. | 2.91 Billion TWD | 86.333% |
| Pharmosa Biopharm Inc. | 144.36 Million TWD | -175.648% |
| PharmaEngine, Inc. | 14.8 Million TWD | -2587.217% |
| Intech Biopharm Corporation | 1.43 Billion TWD | 72.269% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | -24.308% |
| BiOptic Inc. | 93.19 Million TWD | -326.994% |
| TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | -432.824% |
| Senhwa Biosciences, Inc. | 9.6 Million TWD | -4044.881% |
| NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | -3625.426% |
| OBI Pharma, Inc. | 501.05 Million TWD | 20.577% |
| Savior Lifetec Corporation | 270.37 Million TWD | -47.184% |
| Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | -2668.348% |
| Level Biotechnology Inc. | 13.5 Million TWD | -2847.341% |
| Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 79.845% |
| Meribank Biotech Co., Ltd | 34.03 Million TWD | -1069.1% |
| Acepodia, Inc. | 273.81 Million TWD | -45.337% |
| Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | -1845.205% |